In 2019, the FDA permitted generic versions of Eliquis, offering hope for more affordable options. However, these options are currently off-limits in the United States due to an exclusive patent held by Bristol-Meyers Squibb and Pfizer that's in place until November 2026. But here's the silver lining: a generic twin of Eliquis, known as apixaban, can be conveniently acquired by our American people online through our website, ensuring a cost-effective solution.
Alert: Order your 3-month supply by October 12 to help avoid potential customs delays.
Get Semaglutide for $184 or Ozempic for $329
